Ticker ATORXListed on Nasdaq Stockholm
Alligator Bioscience AB
At a glance
Most recent filing on March 24, 2026 — an option exercise by Sören Bregenholt Frederiksen on Mar 20, 2026.
We hold 6 visible filings, going back to May 19, 2025.
Filings we could not classify with confidence are set aside for review, so they are in none of these counts.
Insider trades
What is a MAR filing?5 of 6 shown
- Sören Bregenholt Frederiksen Chief executive officer147,346 SEKOption exercise
- Giléus Invest AB Closely associated: Chief financial officer70,000 SEKOption exercise
- Sören Bregenholt Frederiksen Chief executive officer64,968 SEKOption exercise
- Giléus Invest AB Closely associated: Chief financial officer31,200 SEKOption exercise
- Sören Bregenholt Frederiksen Chief executive officer153,268 SEKOption exercise
Short positions
All short positionsNet short positions of 0.5% or more in Alligator Bioscience AB that are open today, as the regulator publishes them. Together they come to 0.70% of the shares. Positions below 0.5% are not published, so the real total can be higher.
1 open position, together 0.70%. The holders and their history are part of the subscription.
Källa: Finansinspektionen, October 31, 2026.